Genedrive PLC - Manchester-based molecular diagnostics company - Confirms that it expects to benefit from GBP1.2 million of funding, through its participation in a multi-partner grant award from.
By Joe Hoppe Genedrive shares rose after it said it has been awarded a U.K. government grant to validate and implement its CYP2C19 ID Kit for guiding therapy selection in stroke patients in.
Genedrive PLC - Manchester, England-based point-of-care molecular diagnostics company - Awarded a multi-partner grant for the validation of its CYP2X19 ID kit from Innovate UK and the UK government. | June 16, 2023